• Home
  • Search Results

Search Results

Young Adult (18-34)
Adult (35-64)
2414 studies match your search
Not currently enrolling

Parental Education for Sexual Assault Prevention

We want to find out if parents talk to their kids about staying safe from sexual assault before they go to college. Colleges try to help, but we want to know what parents are saying at home first.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Sexual and/or Reproductive Health
  • UNC Students (undergrad, grad, professional)
Visit Location
100% Remote (online, phone, text)
Open

Pilot study to assess and improve quality of 2D and 3D non-invasive diagnostic ultrasound imaging

Dear Colleagues and Students, We are conducting a study to understand how the quality of 2D and 3D ultrasound imaging of different organs (lungs, liver etc) can be improved. You may qualify if you 21 years and older Have no known lung and heart diseases Are not pregnant Participation involves A single laboratory visit Weighing and height measurement Being scanned with non-invasive ultrasound THERE IS NO DIRECT BENEFIT FROM PARTICIPATING IN THIS STUDY, BUT THE DATA WE COLLECT MYA HELP IMPROVE ULTRASOUND IMAGING FOR PATIENTS IN THE FUTURE For information please contact Oleksii Ostras by phone at 919-579-8328 or by email at oleksii@email.unc.edu. Pinton Laboratory, Joint Department of Biomedical Engineering (9212 Mary Ellen Jones Biulding)

Age & Gender
  • 21 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population

Phase 1 pilot study with dose expansion of chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple negative breast cancer

You are asked to participate in this research study of a new immunotherapy combination with chemotherapy in metastatic triple negative breast cancer. Immunotherapy is a form of cancer therapy that activates a patient's immune system to fight the cancer in a patient's body. Unfortunately, only a limited number of patients with metastatic triple negative breast cancer currently respond to FDA approved forms of immunotherapy. CDX-301 and CDX-1140 are two new immunotherapy drugs that are thought to kickstart the immune response against cancers even in patients who do not have an adequate immune response against their cancer to start with. Some studies suggest that combining these drugs with chemotherapy can most effectively kickstart this immune response and lead to improved clinical outcomes.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Not currently enrolling

Sleep after ACL Reconstruction

The purpose of this study is to characterize sleep and to examine the associations between sleep and psychological outcomes after ACL reconstruction

Age & Gender
  • 18 years ~ 35 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Pain
  • Wellness and Lifestyle
  • and 5 more
Visit Location
Open

Intermediate Risk Prostate Cancer Trial

Do you have intermediate risk prostate cancer and don't want to undergo surgery? You may be able to participate in a research study comparing therapy based on genetic testing.

Age & Gender
  • 18 years ~ 99 years
  • Male
Study Interest
  • Cancer (Prostate)
Open

An avocado intervention to increase the nutrient quality of human milk in support of infant cognitive development.

Are you or do you plan to exclusively breastfeed your baby? We are conducting a research study to determine if eating avocados changes the nutrients in your milk and if so, how that affects your baby's recognition memory and overall development. Avocados will be provided!

Age & Gender
  • 3 months ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Eating, Nutrition, and Metabolism
Not currently enrolling

Core Strength Influence on Jumping and Cutting in Females

The purpose of this study is to investigate the intricate relationship between core stability, biomechanics, and performance outcomes in females, aiming to fill the existing knowledge gap by assessing the association of core stability tests with both ACL injury risk biomechanics and overall athletic performance, while also examining the impact of core stability on performance while mentally multitasking.

Age & Gender
  • 18 years ~ 30 years
  • Female
Study Interest
  • Bones, Joints, Muscles
  • Injury/Injury Prevention
  • Women's Health
  • and 3 more
Not currently enrolling

Developing a multicultural viewpoint framework for the providers to comprehend the caregiver's unique grief experiences.

We want to help people from different cultures who live in America. Sometimes they have a hard time getting the right care because they are different from most Americans. We want to learn their understanding of their grief and the cultural factors that influence their grieving process. We want to talk to them and listen to their stories. This way, we can help them trust the doctors and nurses caring for them. We can also help them find more support online. We think this will make them healthier and happier. We also want to show others that having different feelings and beliefs is okay. We hope that by doing this study, we can help the therapists develop a deeper understanding of the grieving experiences and provide culturally appropriate care to their patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Healthy Volunteer or General Population
  • Mental and Emotional Health
  • and 5 more
Visit Location
100% Remote (online, phone, text)
Open

Phase 2 Relapsed or Refractory Multiple Myeloma Study

Have you been diagnosed with relapsed or refractory multiple myeloma? If so you may be able to take part in a research study looking at the safety and efficacy of giving BMS-986393 to patients with multiple myeloma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Multiple Myeloma)
Open

ONC-392 plus Lu 177 vipivotide in ARTA resistant mCRPC

Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)? If so, you may be able to take part in a research study investigating if the study drug together with standard of care drug are safe and well tolerated, and whether two drugs are effective in treating prostate cancer, in comparison with standard of care alone.

Age & Gender
  • 18 years ~ 99 years
  • Male
Study Interest
  • Cancer (Prostate)
  • Men's Health
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research